Twist Bioscience (TWST) total assets

Total assets · fiscal 2026
$1.12B

Twist Bioscience (TWST) had total assets of $1.12B at the end of fiscal 2026 (September 30, 2026). That is 74.8% higher than the $641.86M of fiscal 2025. Figures as of 18 Nov 2026, 05:12 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2026
$1.12B
Change on fiscal 2025
+74.8%
Growth, 5 years
+9.8% a year
Highest on record
$1.12Bfiscal 2026
Lowest on record
$115.79Mfiscal 2018
Fiscal years on record
92018–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Twist Bioscience total assets, in more detail

Over the five fiscal years to 2026 total assets grew at a compound 9.8% a year. Across the 9 fiscal years on record (2018–2026), the highest was $1.12B in fiscal 2026 and the lowest $115.79M in fiscal 2018.

History · 9 fiscal years

Total assets by fiscal year

Twist Bioscience total assets, year by year

Twist Bioscience (TWST) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2026$1.12B 74.8% up
2025$641.86M 4.5% up
2024$614.32M 20.9% down
2023$776.40M 19.2% down
2022$961.38M 36.9% up
2021$702.10M 76.0% up
2020$398.88M 113.3% up
2019$186.99M 61.5% up
2018$115.79M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Twist Bioscience and comparable companies
CompanyTotal assetsFiscal year
TG Therapeutics TGTX$1.06B2025
Praxis Precision Medicines PRAX$937.91M2025
Twist Bioscience TWST$1.12B2026
Protagonist Therapeutics PTGX$668.19M2025
Krystal Biotech KRYS$1.33B2025
10x Genomics TXG$1.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TWST

Twist Bioscience, figure by figure

Twist Bioscience (TWST) overview: price, valuation and scorecardAll health care companies by market value

Twist Bioscience total assets: questions and answers

How large are Twist Bioscience's total assets?

Twist Bioscience (TWST) had total assets of $1.12B at the end of fiscal 2026 (September 30, 2026). That is 74.8% higher than the $641.86M of fiscal 2025.

What is the growth rate of Twist Bioscience's total assets?

Over the five fiscal years to 2026 total assets grew at a compound 9.8% a year.

What are the highest and lowest total assets figures on record for Twist Bioscience?

Across the 9 fiscal years on record (2018–2026), the highest was $1.12B in fiscal 2026 and the lowest $115.79M in fiscal 2018.

How is Twist Bioscience's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Twist Bioscience (TWST) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/TWST/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.